SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
COVID vaccination gives huge boost to post-infection immunity
Fri February 26th - Vaccination is acting as a booster dose for people already enjoying some protection against COVID-19 after exposure to the disease, British scientists reported last night. More
Increased opioid agonist treatment could reduce drug deaths
Fri February 26th - Scaling up the use of opioid agonists could help to reduce drug-related deaths substantially, new international research claims. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
BOOKS ON WOMEN'S HEALTH
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
OTHER NEWS OF INTEREST
WOMEN'S HEALTH NEWS FEED
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

Simple test can identify endometrial cancer

Friday February 12th 2021

A simple urine or vaginal test carried out at home can accurately detect endometrial cancer – removing the need for painful invasive hospital procedures, a new UK study has found.

A proof of concept study by University of Manchester and Manchester University NHS Foundation Trust (MFT) scientists showed that the new detection tool, which uses cytology from cells collected the vagina by gentle lavage or from self-collected urine samples, could be incorporated into clinical practice once large scale trials have been completed.

Professor Emma Crosbie from The University of Manchester led the study, which tested the tool on 103 women with known cancer and 113 with unexplained postmenopausal bleeding.

She said the tool identified 91.7% of women with endometrial cancer, and the proportion of women without cancer who tested negative with the new tool was 88.9%.

Writing in Nature Communications, Prof Crosbie, who is also an honorary consultant in gynaecological oncology at Saint Mary’s Hospital, said the tool is low cost, has quick turnaround times and has the potential for diagnosis at the point of care.

It would replace the need for a hysteroscope examination, which has to be repeated in about 31% of women because of technical difficulties or intolerable pain.

“Our results show that womb cancer cells can be detected in urine and vaginal samples using a microscope,” she said.

“Women who test positive with this test could be referred for diagnostic investigations while women who test negative are safely reassured without the need for unpleasant, invasive, anxiety-provoking and expensive procedures.

“We think our new test could offer a simple, acceptable, and easy to administer solution that could be used in primary care as a triage tool for women with suspected womb cancer.”

Most women present early, following the onset of postmenopausal bleeding and have a good prognosis, but 20% of women present with advanced disease and have a five-year survival rate of just 15%.

Prof Crosbie added: “New strategies to facilitate early diagnosis of womb cancer are urgently needed to enable curative hysterectomy for women who present with biologically aggressive disease.

“However, though postmenopausal bleeding is a recognisable symptom, only 5 to 10% of women with it have sinister underlying pathology, so this test, if adopted, will put these patients’ minds at rest.”

She said a larger, diagnostic accuracy study of women with unexplained postmenstrual bleeding undergoing routine diagnostic investigations was now needed to confirm their findings.

O’Flynn H, Ryan NAJ, Narine N et al. Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples. Nature Communications 11 February 2021. Doi: 10.1038/s41467-021-21257-6.

[abstract]

Tags: Cancer | UK News | Women's Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES